Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone

NCT00339183 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1186

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Panitumumab
DRUG: FOLFIRI

Sponsor

Amgen